STAT+: Up and down the ladder: The latest comings and goings

Delphia Therapeutics hired David Kerstein as its new chief medical officer this week. Kerstein previously served as the chief medical officer for both IDRx and Theseus Pharmaceuticals. His appointment marks a significant addition to Delphia Therapeutics' leadership team. The company is focused on developing new therapeutic solutions. Further details regarding Kerstein's specific responsibilities and the strategic direction he will bring to Delphia Therapeutics are expected to be released following his official onboarding.